<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02005679</url>
  </required_header>
  <id_info>
    <org_study_id>RC-P0008</org_study_id>
    <nct_id>NCT02005679</nct_id>
  </id_info>
  <brief_title>Mini-Mental State (MMS-LS) and Sign Language</brief_title>
  <acronym>MMS-LS</acronym>
  <official_title>Transposition of the Mini-Mental State in Sign Language</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lille Catholic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lille Catholic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In France the prevalence of pre-lingual deafness is between 1 and 1.4 per 1000 habitants, and
      according to very conservative estimates, about 44 000 deaf persons use the sign language.
      Additionally, the prevalence of dementia in France is close to 1% (850 000 dements for a
      total population of 65 millions). The prevalence of dementia in pre-lingual deaf adults has
      also been described and is between 1 and 1.4 /100 000 habitants.

      The Mini Mental State Examination (MMSE) of Folstein is a test recommended to perform the
      cognitive evaluation for the detection of mental disorders including dementia, and a
      consensual French version exists prepared by GRECO (Group of Research and Cognitive
      Assessments). However, to date, there are no simple, rapid and validated screening tests to
      study cognitive disorders in deaf persons who use the sign language. The only tests available
      allow a late diagnosis avoiding an optimal treatment of the patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to assess the intrinsic quality of the tool MMS-LS, a
      mini-mental state examination that has been adapted to the sign language in order to monitor
      cognitive disorders in deaf people who speak sign language.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of internal consistency of MMS-LS test for the diagnosis of cognitive impairment among deaf patients by a correlation analysis followed by Cronbach's alpha test</measure>
    <time_frame>At baseline, 1 year and 2 years follow-up visits</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Description of MMS-LS test results</measure>
    <time_frame>Baseline</time_frame>
    <description>Explanatory Factors are: age, education level, characteristics of the sign language(fluency level, learning age, usage frequency, usage by other family members)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic performance and predictive values of MMS-LS test for acquired dementia.</measure>
    <time_frame>Baseline, 1 year and 2 years follow-up visits</time_frame>
    <description>Sensitivity, specificity, positive and negative predictive values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between MMS-LS score and CDR level</measure>
    <time_frame>Baseline, 1 year and 2 years follow-up visits</time_frame>
    <description>We also check that patients having a suspicious CDR (0.5) have a superior MMS-LS score compared to patients having a CDR ≥ 1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic performance and predictive values of MMS-LS test for suspected dementia.</measure>
    <time_frame>Baseline, 1 year and 2 years follow-up visits</time_frame>
    <description>Sensitivity, specificity, positive and negative predictive values</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">185</enrollment>
  <condition>Prelingual Deafness</condition>
  <condition>Retention Disorders, Cognitive</condition>
  <arm_group>
    <arm_group_label>deaf persons with potential dementia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>application of the mini-mental state test</intervention_name>
    <arm_group_label>deaf persons with potential dementia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults&gt; 18 years

          -  Pre-lingual deafness

          -  Use of French sign language

        Exclusion Criteria:

          -  Refusal to sign the consent

          -  Severe visual impairment with lower acuity (less than 0.5)

          -  Severe motor difficulties impeding the practice of sign language
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benoît Drion, MD</last_name>
    <role>Study Director</role>
    <affiliation>Groupement des Hôpitaux de l'Institut Catholique de Lille, Unité d'Accueil et de Soins des Sourds en Langue des Signes et Réseau Sourds et Santé</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amélie Lansiaux, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Groupement des Hôpitaux de l'Institut Catholique de Lille, Medical Research Department</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle Ridoux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Rennes, Hôpital de Pontchaillou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Corine Gilda Scemama-Ammar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital de la Conception, Pôle psychiatrie, Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charlotte Crinquette, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupement des Hôpitaux de l'Institut Catholique de Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle Bouillevaux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU de Nancy, Unité Régionale d'Accueil et de Soins pour Sourds et malentendants</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Magali Demilly, PhD</last_name>
    <phone>+33 3 20 22 57 00</phone>
    <email>Demilly.Magalie@ghicl.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriela Certad, MD</last_name>
    <phone>+33 3 20 22 57 35</phone>
    <email>certad.gabriela@ghicl.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital de la Conception, Pôle psychiatrie Centre</name>
      <address>
        <city>Marseille</city>
        <state>Bouches-du-Rhône</state>
        <zip>13885</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Corine Gilda Scemama-Ammar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes, Hôpital de Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <state>Ille-et-Vilaine</state>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Isabelle Ridoux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Sophie Le Leuch, Psychologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unité Régionale d'Accueil et de Soins pour Sourds et malentendants - CHRU Nancy</name>
      <address>
        <city>Nancy</city>
        <state>Meurthe-et-Moselle</state>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Isabelle Bouillevaux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupement des Hôpitaux de l'Institut Catholique de Lille</name>
      <address>
        <city>Lille</city>
        <state>Nord Pas de Calais</state>
        <zip>59962</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Benoît Drion, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte Crinquette, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine Leuse, Psychologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine Fleurion, Psychologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2013</study_first_submitted>
  <study_first_submitted_qc>December 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2013</study_first_posted>
  <last_update_submitted>September 19, 2016</last_update_submitted>
  <last_update_submitted_qc>September 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prelingual Deafness</keyword>
  <keyword>Retention Disorders, Cognitive</keyword>
  <keyword>Sign language</keyword>
  <keyword>Mini-Mental State</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Memory Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

